CJC-1295 + Ipamorelin
CJC-1295 with Ipamorelin
GHRH and GHRP combination studied for pulsatile growth hormone release.
Recent Labs Recommended
Therapies related to lean mass, protein synthesis, and strength.
GHRH and GHRP combination studied for pulsatile growth hormone release.
GHRH analog studied for stimulation of the body's own growth hormone.
Orally active ghrelin receptor agonist studied for GH/IGF-1 secretion.
Peptide fragment studied primarily in preclinical models for tissue repair.
A branded compounded blend combining BPC-157 and TB-500, two research peptides individually studied in preclinical models for tissue repair. Neither component is FDA-approved; this specific combination has not been evaluated in clinical trials as a combination.